| Literature DB >> 380730 |
Abstract
A randomised double blind crossover trial of Bromocriptine against an inert placebo was performed in 14 patients with primary sensory urgency. Bromocriptine was found to have no therapeutic advantage for these patients and the possible explanations for this finding are discussed.Entities:
Mesh：
Substances：
Year: 1979 PMID： 380730 DOI： 10.1111/j.1464-410x.1979.tb02866.x
Source DB: PubMed Journal: Br J Urol ISSN： 0007-1331